President Donald Trump has delivered on his promise to shake up FDA by nominating American Enterprise Institute resident fellow and agency veteran Scott Gottlieb to serve as FDA commissioner. Trump's desire to reform what he has called FDA's "slow and burdensome" approval process aligns with Gottlieb's longtime calls to allow the agency more flexibility when reviewing drugs for rare diseases. The White House confirmed the nomination Friday afternoon. Gottlieb has been seen as industry's favorite among the rumored top contenders...